Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Endometrial Neoplasms × Imatinib Mesylate × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 36 Leukemia 26 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Gastrointestinal Stromal Tumors 13 Leukemia, Myeloid, Chronic-Phase 12 Leukemia, Myeloid 6 Brain Neoplasms 6 Prostatic Neoplasms 5 Philadelphia Chromosome 5 Blast Crisis 5 Sarcoma 4 Recurrence 4 Glioblastoma 4 Carcinoma, Non-Small-Cell Lung 4 Bone Marrow Diseases 4 Ovarian Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Hematologic Diseases 3 Bronchiolitis Obliterans Syndrome 3 Breast Neoplasms 3 Stomach Neoplasms 2 Polycythemia Vera 2 Neurofibromatoses 2 Neoplasms by Histologic Type 2 Neoplasms 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Meningioma 2

Interventions

Paclitaxel 19 pembrolizumab 16 Carboplatin 12 Bevacizumab 7 lenvatinib 6 rucaparib 5 Megestrol Acetate 5 Radiation 4 Nivolumab 4 Indocyanine Green 4 Gemcitabine 4 Cisplatin 4 tisotumab vedotin 3 temsirolimus 3 Sirolimus 3 Sentinel Lymph Node Biopsy 3 Doxorubicin 3 olaparib 2 ixabepilone 2 iso-sulfan blue 2 irosustat 2 epacadostat 2 durvalumab 2 copanlisib 2 Trastuzumab 2 Taxes 2 Radiotherapy, Intensity-Modulated 2 Metformin 2 Magnetic Resonance Spectroscopy 2 Letrozole 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡